Cetuximab maintenance therapy may be effective in RAS wild-type metastatic colorectal cancer
bookmark 1. In this randomized phase 2 clinical trial, patients with metastatic colorectal cancer who received cetuximab maintenance therapy had median progression-free and overall survival compared with patients who received observation only during the maintenance phase. The values were found to be improving. 2. There were no statistical differences in adverse events when comparing controls […]